This Review discusses the mechanisms by which common alterations of cancer cell metabolism interfere with immune functions to promote immunoevasion and tumour progression, and avenues to target such alterations for therapeutic purposes.
- Mara De Martino
- Jeffrey C. Rathmell
- Claire Vanpouille-Box